BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
9.98
-0.14 (-1.38%)
At close: Feb 20, 2026, 4:00 PM EST
10.17
+0.19 (1.90%)
After-hours: Feb 20, 2026, 4:31 PM EST
BBOT Market Cap
BBOT has a market cap or net worth of $798.29 million as of February 20, 2026. Its market cap has increased by 226.19% in one year.
Market Cap
798.29M
Enterprise Value
332.89M
1-Year Change
226.19%
Ranking
Category
Stock Price
$9.98
Market Cap Chart
Since February 9, 2024, BBOT's market cap has increased from $38.21M to $798.29M, an increase of 1,989.07%. That is a compound annual growth rate of 345.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 798.29M | -20.29% |
| Dec 31, 2025 | 1.00B | 305.70% |
| Dec 31, 2024 | 246.84M | 545.98% |
| Feb 9, 2024 | 38.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ARS Pharmaceuticals | 934.12M |
| Phathom Pharmaceuticals | 930.14M |
| Aktis Oncology | 925.97M |
| CytomX Therapeutics | 916.65M |
| Eikon Therapeutics | 877.79M |
| Omeros | 833.08M |
| Xencor | 809.79M |
| Bright Minds Biosciences | 798.17M |